Published in J Biol Chem on November 25, 1982
The relation between the divergence of sequence and structure in proteins. EMBO J (1986) 16.66
DOCK 4.0: search strategies for automated molecular docking of flexible molecule databases. J Comput Aided Mol Des (2001) 4.54
Construction of two Escherichia coli amber suppressor genes: tRNAPheCUA and tRNACysCUA. Proc Natl Acad Sci U S A (1986) 3.00
Binding sites in Escherichia coli dihydrofolate reductase communicate by modulating the conformational ensemble. Proc Natl Acad Sci U S A (2000) 2.47
QXP: powerful, rapid computer algorithms for structure-based drug design. J Comput Aided Mol Des (1997) 1.97
Prediction of binding constants of protein ligands: a fast method for the prioritization of hits obtained from de novo design or 3D database search programs. J Comput Aided Mol Des (1998) 1.74
Neutron diffraction studies of Escherichia coli dihydrofolate reductase complexed with methotrexate. Proc Natl Acad Sci U S A (2006) 1.70
Mutations in the dihydrofolate reductase gene of trimethoprim-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1997) 1.66
NMR observation of individual molecules of hydration water bound to DNA duplexes: direct evidence for a spine of hydration water present in aqueous solution. Nucleic Acids Res (1992) 1.65
Characterization of the gene for the chromosomal dihydrofolate reductase (DHFR) of Staphylococcus epidermidis ATCC 14990: the origin of the trimethoprim-resistant S1 DHFR from Staphylococcus aureus? J Bacteriol (1995) 1.55
A link between protein structure and enzyme catalyzed hydrogen tunneling. Proc Natl Acad Sci U S A (1997) 1.53
A disconnect between high-affinity binding and efficient regulation by antifolates and purines in the tetrahydrofolate riboswitch. Chem Biol (2014) 1.49
Coupled motions in enzyme catalysis. Curr Opin Chem Biol (2010) 1.49
Influence of solvent accessibility and intermolecular contacts on atomic mobilities in hemerythrins. Proc Natl Acad Sci U S A (1985) 1.44
Automatic identification and representation of protein binding sites for molecular docking. Protein Sci (1997) 1.43
Cloning and characterization of a novel, plasmid-encoded trimethoprim-resistant dihydrofolate reductase from Staphylococcus haemolyticus MUR313. Antimicrob Agents Chemother (1995) 1.26
Synthetic and crystallographic studies of a new inhibitor series targeting Bacillus anthracis dihydrofolate reductase. J Med Chem (2008) 1.26
Appearance of a new trimethoprim resistance gene, dhfrIX, in Escherichia coli from swine. Antimicrob Agents Chemother (1991) 1.24
Ligand-receptor docking with the Mining Minima optimizer. J Comput Aided Mol Des (2001) 1.23
Characterization of the gene for chromosomal trimethoprim-sensitive dihydrofolate reductase of Staphylococcus aureus ATCC 25923. Antimicrob Agents Chemother (1993) 1.21
A structurally conserved water molecule in Rossmann dinucleotide-binding domains. Protein Sci (2002) 1.17
Early intermediates in the folding of dihydrofolate reductase from Escherichia coli detected by hydrogen exchange and NMR. Protein Sci (1995) 1.16
Self-consistently optimized statistical mechanical energy functions for sequence structure alignment. Protein Sci (1996) 1.15
Glycosidase inhibition: assessing mimicry of the transition state. Org Biomol Chem (2009) 1.14
Stopped-flow NMR spectroscopy: real-time unfolding studies of 6-19F-tryptophan-labeled Escherichia coli dihydrofolate reductase. Proc Natl Acad Sci U S A (1995) 1.14
Significance of structural changes in proteins: expected errors in refined protein structures. Protein Sci (1995) 1.12
Structure and expression of human dihydropteridine reductase. Proc Natl Acad Sci U S A (1987) 1.11
Structural homologies with ATP- and folate-binding enzymes in the crystal structure of folylpolyglutamate synthetase. Proc Natl Acad Sci U S A (1998) 1.03
In pursuit of virtual lead optimization: the role of the receptor structure and ensembles in accurate docking. Proteins (2008) 1.01
Three-dimensional structure of the bifunctional protein PCD/DCoH, a cytoplasmic enzyme interacting with transcription factor HNF1. EMBO J (1995) 1.00
In pursuit of virtual lead optimization: pruning ensembles of receptor structures for increased efficiency and accuracy during docking. Proteins (2009) 0.98
An essential intermediate in the folding of dihydrofolate reductase. Proc Natl Acad Sci U S A (2000) 0.98
Functional concerted motions in the bovine serum retinol-binding protein. J Comput Aided Mol Des (1999) 0.97
The effect of denaturants on protein structure. Protein Sci (1997) 0.96
Long-range structural effects in a second-site revertant of a mutant dihydrofolate reductase. Proc Natl Acad Sci U S A (1993) 0.96
Cloning and characterization of a novel trimethoprim-resistant dihydrofolate reductase from a nosocomial isolate of Staphylococcus aureus CM.S2 (IMCJ1454). Antimicrob Agents Chemother (2005) 0.96
Dihydrofolate reductase: a potential drug target in trypanosomes and leishmania. J Comput Aided Mol Des (1998) 0.95
Refolding of Escherichia coli dihydrofolate reductase: sequential formation of substrate binding sites. Proc Natl Acad Sci U S A (1990) 0.95
A free-energy perturbation study of the binding of methotrexate to mutants of dihydrofolate reductase. Proc Natl Acad Sci U S A (1988) 0.95
Probing the salt bridge in the dihydrofolate reductase-methotrexate complex by using the coordinate-coupled free-energy perturbation method. Proc Natl Acad Sci U S A (1988) 0.94
GIANT: pattern analysis of molecular interactions in 3D structures of protein-small ligand complexes. BMC Bioinformatics (2014) 0.93
NMR-based solution structure of the complex of Lactobacillus casei dihydrofolate reductase with trimethoprim and NADPH. J Biomol NMR (2002) 0.93
Kinked-helices model of the nicotinic acetylcholine receptor ion channel and its complexes with blockers: simulation by the Monte Carlo minimization method. Biophys J (1998) 0.93
Experimental resolution of the free energies of aqueous solvation contributions to ligand-protein binding: quinone-QA site interactions in the photosynthetic reaction center protein. Proc Natl Acad Sci U S A (1993) 0.92
Moritella cold-active dihydrofolate reductase: are there natural limits to optimization of catalytic efficiency at low temperature? J Bacteriol (2003) 0.92
Characterization of dihydrofolate reductase genes from trimethoprim-susceptible and trimethoprim-resistant strains of Enterococcus faecalis. Antimicrob Agents Chemother (1999) 0.92
Identifying residue-residue clashes in protein hybrids by using a second-order mean-field approach. Proc Natl Acad Sci U S A (2003) 0.92
Both ATPase domains of ClpA are critical for processing of stable protein structures. J Biol Chem (2009) 0.92
FLASHFLOOD: a 3D field-based similarity search and alignment method for flexible molecules. J Comput Aided Mol Des (2001) 0.91
Protein fragments as probes in the study of protein folding mechanisms: differential effects of dihydrofolate reductase fragments on the refolding of the intact protein. Proc Natl Acad Sci U S A (1989) 0.91
Protein folding: how the mechanism of GroEL action is defined by kinetics. Proc Natl Acad Sci U S A (1997) 0.90
Site-Identification by Ligand Competitive Saturation (SILCS) assisted pharmacophore modeling. J Comput Aided Mol Des (2014) 0.89
Dynamics of trimethoprim bound to dihydrofolate reductase. Proc Natl Acad Sci U S A (1988) 0.88
Detergent-induced conformational changes of Humicola lanuginosa lipase studied by fluorescence spectroscopy. Biophys J (2000) 0.86
19F-n.m.r. studies of 3',5'-difluoromethotrexate binding to Lactobacillus casei dihydrofolate reductase. Molecular motion and coenzyme-induced conformational changes. Biochem J (1984) 0.86
Importance of a hydrophobic residue in binding and catalysis by dihydrofolate reductase. Proc Natl Acad Sci U S A (1986) 0.86
Crystal structures of Klebsiella pneumoniae dihydrofolate reductase bound to propargyl-linked antifolates reveal features for potency and selectivity. Antimicrob Agents Chemother (2014) 0.85
Comparative hydrogen-deuterium exchange for a mesophilic vs thermophilic dihydrofolate reductase at 25 °C: identification of a single active site region with enhanced flexibility in the mesophilic protein. Biochemistry (2011) 0.84
Molecular docking studies on DMDP derivatives as human DHFR inhibitors. Bioinformation (2008) 0.84
Characterization of a novel bifunctional dihydropteroate synthase/dihydropteroate reductase enzyme from Helicobacter pylori. J Bacteriol (2007) 0.84
Target identification by chromatographic co-elution: monitoring of drug-protein interactions without immobilization or chemical derivatization. Mol Cell Proteomics (2012) 0.83
Structure of a partially unfolded form of Escherichia coli dihydrofolate reductase provides insight into its folding pathway. Protein Sci (2014) 0.83
Isolation and characterization of a variant dihydrofolate reductase cDNA from methotrexate-resistant murine L5178Y cells. Nucleic Acids Res (1990) 0.83
Pharmacophore modeling using site-identification by ligand competitive saturation (SILCS) with multiple probe molecules. J Chem Inf Model (2015) 0.83
Structure and dynamics in solution of the complex of Lactobacillus casei dihydrofolate reductase with the new lipophilic antifolate drug trimetrexate. Protein Sci (1999) 0.83
AutoGrow 3.0: an improved algorithm for chemically tractable, semi-automated protein inhibitor design. J Mol Graph Model (2013) 0.82
Comparison of protein surfaces using a genetic algorithm. J Comput Aided Mol Des (1997) 0.82
TrixX: structure-based molecule indexing for large-scale virtual screening in sublinear time. J Comput Aided Mol Des (2007) 0.81
Interpretable correlation descriptors for quantitative structure-activity relationships. J Cheminform (2009) 0.81
Effects of fluorine substitution on the structure and dynamics of complexes of dihydrofolate reductase (Escherichia coli). Biophys J (1997) 0.81
A 1H n.m.r. study of the role of the glutamate moiety in the binding of methotrexate to Lactobacillus casei dihydrofolate reductase. Br J Pharmacol (1984) 0.80
A comparison of heuristic search algorithms for molecular docking. J Comput Aided Mol Des (1997) 0.80
Evaluation of a method for controlling molecular scaffold diversity in de novo ligand design. J Comput Aided Mol Des (1997) 0.80
Selective coupling of methotrexate to peptide hormone carriers through a gamma-carboxamide linkage of its glutamic acid moiety: benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate activation in salt coupling. Proc Natl Acad Sci U S A (1993) 0.79
Molecular Modeling of Geometries, Charge Distributions, and Binding Energies of Small, Drug-Like Molecules Containing Nitrogen Heterocycles and Exocyclic Amino Groups in the Gas Phase and Aqueous Solution. J Chem Theory Comput (2008) 0.79
Factors that cause trimethoprim resistance in Streptococcus pyogenes. Antimicrob Agents Chemother (2014) 0.79
pH-dependent conformational changes in Escherichia coli dihydrofolate reductase revealed by Raman difference spectroscopy. Biophys J (1997) 0.78
Functional role for the conformationally mobile phenylalanine 223 in the reaction of methylenetetrahydrofolate reductase from Escherichia coli. Biochemistry (2009) 0.78
Identification of novel potential antibiotics against Staphylococcus using structure-based drug screening targeting dihydrofolate reductase. J Chem Inf Model (2014) 0.77
Fluorescent biphenyl derivatives of phenylalanine suitable for protein modification. Biochemistry (2013) 0.77
LigMerge: a fast algorithm to generate models of novel potential ligands from sets of known binders. Chem Biol Drug Des (2012) 0.77
Identification and energetic ranking of possible docking sites for pterin on dihydrofolate reductase. J Comput Aided Mol Des (1998) 0.76
Combinatorial library-based design with Basis Products. J Comput Aided Mol Des (2009) 0.75
Tryptophan-based fluorophores for studying protein conformational changes. Bioorg Med Chem (2014) 0.75
Conformational analysis of environmental agents: use of X-ray crystallographic data to determine molecular reactivity. Environ Health Perspect (1985) 0.75
3H-n.m.r. studies of multiple conformations and dynamic processes in complexes of folate and methotrexate with Lactobacillus casei dihydrofolate reductase. Biochem J (1994) 0.75
Structural mimicry of adenosine by the antitumor agents 4-methoxy- and 4-amino-8-(beta-D-ribofuranosylamino)pyrimido[5,4-d]pyrimidine as viewed by a molecular modeling method. Proc Natl Acad Sci U S A (1989) 0.75
DNA synthesis as a therapeutic target: the first 65 years. FASEB J (2012) 0.75
Quantitative PET Reporter Gene Imaging with [(11)C]Trimethoprim. Mol Ther (2017) 0.75
The use of local surface properties for molecular superimposition. J Mol Model (2008) 0.75
A branch-and-bound method for optimal atom-type assignment in de novo ligand design. J Comput Aided Mol Des (1998) 0.75
Selectivity analysis of 5-(arylthio)-2,4-diaminoquinazolines as inhibitors of Candida albicans dihydrofolate reductase by molecular dynamics simulations. J Comput Aided Mol Des (2000) 0.75
Three-dimensional structure of poliovirus at 2.9 A resolution. Science (1985) 11.47
Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science (1994) 5.57
Loop and subdomain movements in the mechanism of Escherichia coli dihydrofolate reductase: crystallographic evidence. Biochemistry (1997) 5.46
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase. Science (1991) 5.42
Serine proteases: structure and mechanism of catalysis. Annu Rev Biochem (1977) 5.37
Crystal structure of a complex between electron transfer partners, cytochrome c peroxidase and cytochrome c. Science (1992) 4.82
Crystal structures of human DNA polymerase beta complexed with gapped and nicked DNA: evidence for an induced fit mechanism. Biochemistry (1997) 4.55
Crystal structure of rat DNA polymerase beta: evidence for a common polymerase mechanism. Science (1994) 4.11
Structure of subtilisin BPN' at 2.5 angström resolution. Nature (1969) 3.98
The crystal structure of Dps, a ferritin homolog that binds and protects DNA. Nat Struct Biol (1998) 3.02
The 2.6-A crystal structure of Pseudomonas putida cytochrome P-450. J Biol Chem (1985) 2.95
Dihydrofolate reductase: x-ray structure of the binary complex with methotrexate. Science (1977) 2.88
The mental health of patients with a chief complaint of chronic fatigue. A prospective evaluation and follow-up. Arch Intern Med (1988) 2.85
Molecular tectonic model of virus structural transitions: the putative cell entry states of poliovirus. J Virol (2000) 2.74
Crystal structure of the biphenyl-cleaving extradiol dioxygenase from a PCB-degrading pseudomonad. Science (1995) 2.68
Three-dimensional structure of poliovirus serotype 1 neutralizing determinants. J Virol (1988) 2.67
Three-dimensional structure of poliovirus receptor bound to poliovirus. Proc Natl Acad Sci U S A (2000) 2.64
Crystal structure of yeast cytochrome c peroxidase refined at 1.7-A resolution. J Biol Chem (1984) 2.56
Low-resolution electron-density and anomalous-scattering-density maps of Chromatium high-potential iron protein. J Mol Biol (1968) 2.46
Crystal structure of avian dihydrofolate reductase containing phenyltriazine and NADPH. J Biol Chem (1982) 2.45
The stereochemistry of peroxidase catalysis. J Biol Chem (1980) 2.35
Crystal structure of soybean lipoxygenase L-1 at 1.4 A resolution. Biochemistry (1996) 2.34
Depression and somatization in the chronic fatigue syndrome. Am J Med (1991) 2.33
Crystal structures of human DNA polymerase beta complexed with DNA: implications for catalytic mechanism, processivity, and fidelity. Biochemistry (1996) 2.25
Chymotrypsinogen: 2.5-angstrom crystal structure, comparison with alpha-chymotrypsin, and implications for zymogen activation. Biochemistry (1970) 2.23
Subtilisin; a stereochemical mechanism involving transition-state stabilization. Biochemistry (1972) 2.13
The frequency of the chronic fatigue syndrome in patients with symptoms of persistent fatigue. Ann Intern Med (1988) 2.11
The crystal structure of an unusual processivity factor, herpes simplex virus UL42, bound to the C terminus of its cognate polymerase. Mol Cell (2000) 2.09
Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution. Protein Sci (1994) 2.06
Dihydrofolate reductase from Lactobacillus casei. X-ray structure of the enzyme methotrexate.NADPH complex. J Biol Chem (1978) 1.94
A comparison of Fe 4 S 4 clusters in high-potential iron protein and in ferredoxin. Proc Natl Acad Sci U S A (1972) 1.93
Crystallographic structure and functional interpretation of the cytoplasmic domain of erythrocyte membrane band 3. Blood (2000) 1.92
Crystal structure of the tenth type III cell adhesion module of human fibronectin. J Mol Biol (1994) 1.91
Directed mutagenesis of dihydrofolate reductase. Science (1983) 1.88
Evolutionary relationships among extradiol dioxygenases. J Bacteriol (1996) 1.88
Crystal structure of unliganded Escherichia coli dihydrofolate reductase. Ligand-induced conformational changes and cooperativity in binding. Biochemistry (1991) 1.86
Enzyme-DNA interactions required for efficient nucleotide incorporation and discrimination in human DNA polymerase beta. J Biol Chem (1996) 1.85
Synaptic plasma membranes from rat brain synaptosomes: isolation and partial characterization. Biochim Biophys Acta (1971) 1.84
X-ray crystallographic study of boronic acid adducts with subtilisin BPN' (Novo). A model for the catalytic transition state. J Biol Chem (1975) 1.82
Identification of variable domains of the attachment (G) protein of subgroup A respiratory syncytial viruses. J Gen Virol (1991) 1.79
The structure of oxidized cytochrome c 2 of Rhodospirillum rubrum. J Biol Chem (1973) 1.73
Three-dimensional structure of a mouse-adapted type 2/type 1 poliovirus chimera. EMBO J (1991) 1.72
Analysis of respiratory syncytial virus strain variation in successive epidemics in one city. J Clin Microbiol (1994) 1.72
Crystal structures of Escherichia coli dihydrofolate reductase: the NADP+ holoenzyme and the folate.NADP+ ternary complex. Substrate binding and a model for the transition state. Biochemistry (1990) 1.71
The structure and oligomerization of the yeast arginine methyltransferase, Hmt1. Nat Struct Biol (2000) 1.69
Functional role of aspartic acid-27 in dihydrofolate reductase revealed by mutagenesis. Science (1986) 1.68
Crystal structures of recombinant human dihydrofolate reductase complexed with folate and 5-deazafolate. Biochemistry (1990) 1.66
What makes the patient-doctor relationship therapeutic? Exploring the connexional dimension of medical care. Ann Intern Med (1988) 1.64
Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci U S A (1992) 1.63
In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease. Antimicrob Agents Chemother (1999) 1.63
The splicing factor-associated protein, p32, regulates RNA splicing by inhibiting ASF/SF2 RNA binding and phosphorylation. EMBO J (1999) 1.63
Refined crystal structures of Escherichia coli and chicken liver dihydrofolate reductase containing bound trimethoprim. J Biol Chem (1985) 1.62
Siderophore presence in sputa of cystic fibrosis patients. Infect Immun (1991) 1.61
Crystal structures of Escherichia coli and Lactobacillus casei dihydrofolate reductase refined at 1.7 A resolution. II. Environment of bound NADPH and implications for catalysis. J Biol Chem (1982) 1.61
Orbital rhabdomyosarcoma. An analysis of 62 cases. Am J Ophthalmol (1966) 1.60
Structural domains of the poliovirus polyprotein are major determinants for proteolytic cleavage at Gln-Gly pairs. J Biol Chem (1988) 1.60
Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design. Curr Biol (1994) 1.57
Alpha-delta sleep in patients with a chief complaint of chronic fatigue. South Med J (1994) 1.55
Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 4. Incorporation of P1 lactam moieties as L-glutamine replacements. J Med Chem (1999) 1.55
Two-Angstrom crystal structure of oxidized Chromatium high potential iron protein. J Biol Chem (1974) 1.55
Three-dimensional structure of Theiler virus. Proc Natl Acad Sci U S A (1992) 1.52
Structure of and kinetic channelling in bifunctional dihydrofolate reductase-thymidylate synthase. Nat Struct Biol (1994) 1.47
The low yield of physical examinations and laboratory investigations of patients with chronic fatigue. Am J Med Sci (1990) 1.47
A structural basis for metal ion mutagenicity and nucleotide selectivity in human DNA polymerase beta. Biochemistry (1996) 1.45
A hypothetical model of the cytochrome c peroxidase . cytochrome c electron transfer complex. J Biol Chem (1980) 1.44
An x-ray crystallographic study of the binding of peptide chloromethyl ketone inhibitors to subtilisin BPN'. Biochemistry (1972) 1.44
Nitrogenase metalloclusters: structures, organization, and synthesis. J Bacteriol (1993) 1.42
A cluster exposed: structure of the Rieske ferredoxin from biphenyl dioxygenase and the redox properties of Rieske Fe-S proteins. Structure (2000) 1.41
A proposed model for interaction of polypeptides with RNA. Proc Natl Acad Sci U S A (1974) 1.39
Atomic coordinates for subtilisin BPN' (or Novo). Biochem Biophys Res Commun (1971) 1.37
Structure of the human cytomegalovirus protease catalytic domain reveals a novel serine protease fold and catalytic triad. Cell (1996) 1.37
Structural bases for function in cytochromes c. An interpretation of comparative x-ray and biochemical data. J Biol Chem (1973) 1.36
An electron microscopic study of lesion-induced synaptogenesis in the dentate gyrus of the adult rat. I. Magnitude and time course of degeneration. Brain Res (1976) 1.36
The crystal structure of cytochrome c peroxidase. J Biol Chem (1980) 1.35
Analysis of relatedness of subgroup A respiratory syncytial viruses isolated worldwide. Virus Res (1992) 1.30
Molecular basis for the stabilization and inhibition of 2, 3-dihydroxybiphenyl 1,2-dioxygenase by t-butanol. J Biol Chem (1998) 1.30
Structure of the iron-sulfur cluster in the Chromatius iron protein at 2.25 Angstrom resolution. Cold Spring Harb Symp Quant Biol (1972) 1.30
Crystal structure of a novel trimethoprim-resistant dihydrofolate reductase specified in Escherichia coli by R-plasmid R67. Biochemistry (1986) 1.29
"How much do you get paid if I volunteer?" Suggested institutional policy on reward, consent, and research. Hosp Health Serv Adm (1994) 1.26
Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor. Antimicrob Agents Chemother (2005) 1.25
Polypeptide halomethyl ketones bind to serine proteases as analogs of the tetrahedral intermediate. X-ray crystallographic comparison of lysine- and phenylalanine-polypeptide chloromethyl ketone-inhibited subtilisin. J Biol Chem (1976) 1.25
Tripeptide aldehyde inhibitors of human rhinovirus 3C protease: design, synthesis, biological evaluation, and cocrystal structure solution of P1 glutamine isosteric replacements. J Med Chem (1998) 1.24
Electrostatic channeling in the bifunctional enzyme dihydrofolate reductase-thymidylate synthase. J Mol Biol (1996) 1.23
Steady-state kinetic characterization and crystallization of a polychlorinated biphenyl-transforming dioxygenase. J Biol Chem (2000) 1.21
Structure of the complex between the Fab fragment of a neutralizing antibody for type 1 poliovirus and its viral epitope. Nat Struct Biol (1995) 1.20
An engineered disulfide bond in dihydrofolate reductase. Biochemistry (1987) 1.20